Jennifer M. Kirk - Jul 29, 2024 Form 4 Insider Report for Medtronic plc (MDT)

Role
Chief Accounting Officer
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Jul 29, 2024
Transactions value $
$0
Form type
4
Date filed
7/31/2024, 07:56 PM
Previous filing
Jul 17, 2024
Next filing
Aug 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Award $0 +7.81K +57.02% $0.00 21.5K Jul 29, 2024 Direct F1, F2
transaction MDT Ordinary Shares Award $0 +6.33K +29.4% $0.00 27.8K Jul 29, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Unit Award $0 +7.81K $0.00 7.81K Jul 29, 2024 Performance Share Units 7.81K Direct F4, F5, F6
transaction MDT Performance Share Unit Award $0 +3.13K $0.00 3.13K Jul 29, 2024 Performance Share Units 3.13K Direct F4, F7
transaction MDT Stock Option (Right to Buy) Award $0 +1.54K $0.00 1.54K Jul 29, 2024 Ordinary Shares 1.54K $80.00 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F2 Includes 196 shares acquired through dividend reinvestment and 299 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.
F3 Restrictions on the award shall lapse 33% each year following the Grant Date.
F4 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F5 Vests on July 29, 2027.
F6 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 7,813 shares will be issued. If maximum performance metrics are achieved, 15,626 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F7 Vests on December 6, 2026.
F8 These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.